Screener
AngioDynamics ANGO Med Tech — Gross Margin %
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept ango:GrossMarginPercentage.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| (in thousands) | Year ended May 31, 2026 | Year ended May 31, 2025 | Year ended May 31, 2024 |
|---|---|---|---|
| Med Tech Net Sales | $149,954 | $126,653 | $106,403 |
| Med Tech Cost of Sales (exclusive of intangible amortization) | $54,598 | $48,138 | $39,205 |
| Gross Margin | $95,356 | $78,515 | $67,198 |
| Gross Margin % | 63.6% | 62.0% | 63.2% |
| Med Device Net Sales | $170,220 | $165,845 | $197,511 |
| Med Device Cost of Sales (exclusive of intangible amortization) | $90,684 | $86,655 | $110,011 |
| Gross Margin | $79,536 | $79,190 | $87,500 |
| Gross Margin % | 46.7% | 47.7% | 44.3% |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's med tech — gross margin %?
- AngioDynamics (ANGO) reported med tech — gross margin % of 0.3% in Q1 2026.
- What is the long-term trend for AngioDynamics's med tech — gross margin %?
- Over 3 years (2022 to 2026), AngioDynamics's med tech — gross margin % has grown at a -1.4% compound annual growth rate (CAGR), from 198.8% to 190.3%.
- What does med tech — gross margin % mean?
- Gross margin percentage represents the proportion of net sales remaining after deducting the direct costs of goods sold for the Med Tech segment. It is a key performance indicator of manufacturing efficiency, product mix, and pricing strategy. A higher margin indicates that the segment is effectively managing production costs relative to its revenue generation.
Ask your AI about AngioDynamics's med tech — gross margin %.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude